Efficacy of celecoxib for pain relief and antipyresis in pregnant women receiving misoprostol for termination of pregnancy
Phase 2
Recruiting
- Conditions
- Women with intrauterine pregnancy requesting therapeutic abortion for any indications
- Registration Number
- TCTR20160109001
- Lead Sponsor
- Songkhlanakarind hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 64
Inclusion Criteria
Women with intrauterine pregnancy requesting therapeutic abortion for any indications and Gestational age 14-24 weeks which is confirmed by USG
Exclusion Criteria
- Allergy to NSAIDs/Sulfa
- Contraindicate for Celecoxib
- History of fever, PROM, vaginal bleeding, abdominal pain
- History of previous induced abortion by medication or devices
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain score every hour after taking first dose misoprostol in intervention and control group within 24 hours after taking first dose misoprostol VAS
- Secondary Outcome Measures
Name Time Method Body temperature every hour after taking first dose misoprostol in intervention and control group within 24 hours after taking first dose misoprostol Infarated Thermometer